Publication | Closed Access

Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis

Braf-mutant Tumor SecretomeSignal TransductionSignaling PathwayMedicineSrc InhibitionCancer Cell BiologyInvasive PhenotypeRadiation OncologyCancer BiologyCell BiologyCell SignalingTumor BiologyCancer Growth